đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
The purpose of this study is to conduct long-term surveillance for efficacy...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-18
Trial ID
NCT02207816
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
The aim of this study is to evaluate the reactogenicity, safety and immunog...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-16
Trial ID
NCT00263666
Treatments Being Tested
The purpose of this study is to assess the immunogenicity in terms of antib...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-18
Trial ID
NCT00678301
Treatments Being Tested
The purpose of this observer-blind study is to gather key efficacy, safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-27
Trial ID
NCT00866619
This study is a Phase IV, open, randomized, multi-center, controlled vaccin...
Status
Completed
Location
Centro de Estudios en Infectologia Pediatrica - CEIP
Start Date
2013-05
Trial ID
NCT01831050
The aim of the study is to evaluate the immunogenicity, safety and reactoge...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06-01
Trial ID
NCT01175083
Treatments Being Tested
This purpose of the study is to assess the safety and immunogenicity of a G...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-07
Trial ID
NCT01098474
Treatments Being Tested